Amgen cites inflation, pressure on drug prices in 450-person layoff
Amgen is laying off about 450 workers, the company told Endpoints News, just two months after letting go 300 staffers.
A spokesperson said the layoffs impact less than 2% of the California biopharma’s total headcount, which was about 24,000 workers, per a JP Morgan Healthcare Conference presentation in January.
“We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation so that we can continue to deliver value for our patients, staff and shareholders,” the spokesperson said in an emailed statement to Endpoints Thursday after the markets closed, noting the affected people will be offered severance and transition services.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,500+ biopharma pros reading Endpoints daily — and it's free.